Effects of cardioselective K ATP channel antagonism on basal, stimulated, and ischaemic myocardial function in in vivo failing canine heart

Walter F. Saavedra, Nazareno Paolocci, David A Kass

Research output: Contribution to journalArticle

Abstract

1. Inhibition of cardiomyocyte-specific ATP-sensitive potassium (K ATP) channels prolongs the action potential during intense ischaemia with attendant antiarrhythmic effects. However, this is accompanied by contractile depression in some models. These changes may be particularly troublesome in dilated cardiomyopathic hearts that display basal systolic dysfunction, limited energy reserve, and prolonged repolarization favouring arrhythmia. Mechanical effects of selective myocyte K ATP channel blockade on basal, β-adrenergic stimulated, and ischemic responses were therefore tested in dogs with cardiac failure induced by tachypacing. 2. Cardiovascular function was assessed by pressure - dimension relationships in 10 conscious, chronically instrumented dogs (sonomicrometry/micromanometry), with or without cardiac failure. Cardiomyocyte K ATP channels were inhibited by HMR 1098, and data obtained under basal conditions, during epinephrine infusion to raise metabolic demand, during regional ischaemia, and with combined ischaemia + epinephrine. 3. HMR 1098 had no effect on baseline cardiac function nor did it induce arrhythmia in normal or failing hearts. Epinephrine raised cardiac work 65% and oxygen consumption 55%, yet HMR 1098 had no functional effect in either heart condition. Regional ischaemia with or without epinephrine co-stimulation depressed regional and global function, yet both were also unaffected by HMR 1098. There was minimal arrhythmia without HMR 1098, and drug infusion did not alter this. 4. Thus, myocyte-K ATP channels play a negligible role modulating intact in vivo cardiac contraction or arrhythmia in normal and failing heart with and without increased metabolic demand and/or regional ischaemia. This supports the feasibility of administering such agents to depressed hearts, despite underlying contractile and electrophysiologic abnormalities.

Original languageEnglish (US)
Pages (from-to)657-662
Number of pages6
JournalBritish Journal of Pharmacology
Volume135
Issue number3
StatePublished - 2002

Fingerprint

Canidae
Ischemia
Adenosine Triphosphate
Epinephrine
Cardiac Arrhythmias
Cardiac Myocytes
Muscle Cells
Heart Failure
Dogs
KATP Channels
Oxygen Consumption
Adrenergic Agents
Action Potentials
HMR 1098
Pressure
Pharmaceutical Preparations

Keywords

  • Contractility
  • Heart failure
  • HMR 1098
  • Ischaemia
  • K channels
  • Ventricular function

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{deb6438a040a4f748f64b889c1d2176d,
title = "Effects of cardioselective K ATP channel antagonism on basal, stimulated, and ischaemic myocardial function in in vivo failing canine heart",
abstract = "1. Inhibition of cardiomyocyte-specific ATP-sensitive potassium (K ATP) channels prolongs the action potential during intense ischaemia with attendant antiarrhythmic effects. However, this is accompanied by contractile depression in some models. These changes may be particularly troublesome in dilated cardiomyopathic hearts that display basal systolic dysfunction, limited energy reserve, and prolonged repolarization favouring arrhythmia. Mechanical effects of selective myocyte K ATP channel blockade on basal, β-adrenergic stimulated, and ischemic responses were therefore tested in dogs with cardiac failure induced by tachypacing. 2. Cardiovascular function was assessed by pressure - dimension relationships in 10 conscious, chronically instrumented dogs (sonomicrometry/micromanometry), with or without cardiac failure. Cardiomyocyte K ATP channels were inhibited by HMR 1098, and data obtained under basal conditions, during epinephrine infusion to raise metabolic demand, during regional ischaemia, and with combined ischaemia + epinephrine. 3. HMR 1098 had no effect on baseline cardiac function nor did it induce arrhythmia in normal or failing hearts. Epinephrine raised cardiac work 65{\%} and oxygen consumption 55{\%}, yet HMR 1098 had no functional effect in either heart condition. Regional ischaemia with or without epinephrine co-stimulation depressed regional and global function, yet both were also unaffected by HMR 1098. There was minimal arrhythmia without HMR 1098, and drug infusion did not alter this. 4. Thus, myocyte-K ATP channels play a negligible role modulating intact in vivo cardiac contraction or arrhythmia in normal and failing heart with and without increased metabolic demand and/or regional ischaemia. This supports the feasibility of administering such agents to depressed hearts, despite underlying contractile and electrophysiologic abnormalities.",
keywords = "Contractility, Heart failure, HMR 1098, Ischaemia, K channels, Ventricular function",
author = "Saavedra, {Walter F.} and Nazareno Paolocci and Kass, {David A}",
year = "2002",
language = "English (US)",
volume = "135",
pages = "657--662",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Effects of cardioselective K ATP channel antagonism on basal, stimulated, and ischaemic myocardial function in in vivo failing canine heart

AU - Saavedra, Walter F.

AU - Paolocci, Nazareno

AU - Kass, David A

PY - 2002

Y1 - 2002

N2 - 1. Inhibition of cardiomyocyte-specific ATP-sensitive potassium (K ATP) channels prolongs the action potential during intense ischaemia with attendant antiarrhythmic effects. However, this is accompanied by contractile depression in some models. These changes may be particularly troublesome in dilated cardiomyopathic hearts that display basal systolic dysfunction, limited energy reserve, and prolonged repolarization favouring arrhythmia. Mechanical effects of selective myocyte K ATP channel blockade on basal, β-adrenergic stimulated, and ischemic responses were therefore tested in dogs with cardiac failure induced by tachypacing. 2. Cardiovascular function was assessed by pressure - dimension relationships in 10 conscious, chronically instrumented dogs (sonomicrometry/micromanometry), with or without cardiac failure. Cardiomyocyte K ATP channels were inhibited by HMR 1098, and data obtained under basal conditions, during epinephrine infusion to raise metabolic demand, during regional ischaemia, and with combined ischaemia + epinephrine. 3. HMR 1098 had no effect on baseline cardiac function nor did it induce arrhythmia in normal or failing hearts. Epinephrine raised cardiac work 65% and oxygen consumption 55%, yet HMR 1098 had no functional effect in either heart condition. Regional ischaemia with or without epinephrine co-stimulation depressed regional and global function, yet both were also unaffected by HMR 1098. There was minimal arrhythmia without HMR 1098, and drug infusion did not alter this. 4. Thus, myocyte-K ATP channels play a negligible role modulating intact in vivo cardiac contraction or arrhythmia in normal and failing heart with and without increased metabolic demand and/or regional ischaemia. This supports the feasibility of administering such agents to depressed hearts, despite underlying contractile and electrophysiologic abnormalities.

AB - 1. Inhibition of cardiomyocyte-specific ATP-sensitive potassium (K ATP) channels prolongs the action potential during intense ischaemia with attendant antiarrhythmic effects. However, this is accompanied by contractile depression in some models. These changes may be particularly troublesome in dilated cardiomyopathic hearts that display basal systolic dysfunction, limited energy reserve, and prolonged repolarization favouring arrhythmia. Mechanical effects of selective myocyte K ATP channel blockade on basal, β-adrenergic stimulated, and ischemic responses were therefore tested in dogs with cardiac failure induced by tachypacing. 2. Cardiovascular function was assessed by pressure - dimension relationships in 10 conscious, chronically instrumented dogs (sonomicrometry/micromanometry), with or without cardiac failure. Cardiomyocyte K ATP channels were inhibited by HMR 1098, and data obtained under basal conditions, during epinephrine infusion to raise metabolic demand, during regional ischaemia, and with combined ischaemia + epinephrine. 3. HMR 1098 had no effect on baseline cardiac function nor did it induce arrhythmia in normal or failing hearts. Epinephrine raised cardiac work 65% and oxygen consumption 55%, yet HMR 1098 had no functional effect in either heart condition. Regional ischaemia with or without epinephrine co-stimulation depressed regional and global function, yet both were also unaffected by HMR 1098. There was minimal arrhythmia without HMR 1098, and drug infusion did not alter this. 4. Thus, myocyte-K ATP channels play a negligible role modulating intact in vivo cardiac contraction or arrhythmia in normal and failing heart with and without increased metabolic demand and/or regional ischaemia. This supports the feasibility of administering such agents to depressed hearts, despite underlying contractile and electrophysiologic abnormalities.

KW - Contractility

KW - Heart failure

KW - HMR 1098

KW - Ischaemia

KW - K channels

KW - Ventricular function

UR - http://www.scopus.com/inward/record.url?scp=0036008605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036008605&partnerID=8YFLogxK

M3 - Article

C2 - 11834613

AN - SCOPUS:0036008605

VL - 135

SP - 657

EP - 662

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 3

ER -